Mohammed I. El–Gamal

812 total citations
37 papers, 609 citations indexed

About

Mohammed I. El–Gamal is a scholar working on Molecular Biology, Organic Chemistry and Pathology and Forensic Medicine. According to data from OpenAlex, Mohammed I. El–Gamal has authored 37 papers receiving a total of 609 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 14 papers in Organic Chemistry and 6 papers in Pathology and Forensic Medicine. Recurrent topics in Mohammed I. El–Gamal's work include Synthesis and biological activity (9 papers), Melanoma and MAPK Pathways (8 papers) and Legionella and Acanthamoeba research (5 papers). Mohammed I. El–Gamal is often cited by papers focused on Synthesis and biological activity (9 papers), Melanoma and MAPK Pathways (8 papers) and Legionella and Acanthamoeba research (5 papers). Mohammed I. El–Gamal collaborates with scholars based in United Arab Emirates, Egypt and South Korea. Mohammed I. El–Gamal's co-authors include Hanan S. Anbar, Chang‐Hyun Oh, Mohammed S. Abdel‐Maksoud, Seyed–Omar Zaraei, Mahmoud M. Gamal El‐Din, Hamadeh Tarazi, Kamel H. Shaker, Karin Seifert, Chang Hyun Oh and Jean Sévigny and has published in prestigious journals such as Journal of Agricultural and Food Chemistry, Journal of Medicinal Chemistry and The Journal of Organic Chemistry.

In The Last Decade

Mohammed I. El–Gamal

36 papers receiving 595 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mohammed I. El–Gamal United Arab Emirates	15	318	227	93	77	56	37	609
Tony Eight Lin Taiwan	18	644 2.0×	175 0.8×	220 2.4×	53 0.7×	45 0.8×	60	881
Naohisa Ogo Japan	14	344 1.1×	111 0.5×	189 2.0×	60 0.8×	70 1.3×	40	632
Masahiro Neya Japan	12	363 1.1×	173 0.8×	74 0.8×	38 0.5×	22 0.4×	22	614
Patrick Corsino United States	14	366 1.2×	155 0.7×	193 2.1×	39 0.5×	41 0.7×	18	690
Chong Hak Chae South Korea	14	347 1.1×	113 0.5×	106 1.1×	33 0.4×	35 0.6×	48	582
Claudio Zambaldo United States	16	899 2.8×	285 1.3×	128 1.4×	49 0.6×	24 0.4×	21	1.1k
E. Hampton Sessions United States	16	295 0.9×	240 1.1×	117 1.3×	56 0.7×	13 0.2×	20	635
Tijana Stanković Serbia	18	386 1.2×	92 0.4×	183 2.0×	33 0.4×	37 0.7×	34	670
Malina Patel United States	4	420 1.3×	112 0.5×	259 2.8×	45 0.6×	36 0.6×	5	679

Countries citing papers authored by Mohammed I. El–Gamal

Since Specialization

Citations

This map shows the geographic impact of Mohammed I. El–Gamal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohammed I. El–Gamal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohammed I. El–Gamal more than expected).

Fields of papers citing papers by Mohammed I. El–Gamal

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mohammed I. El–Gamal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohammed I. El–Gamal. The network helps show where Mohammed I. El–Gamal may publish in the future.

Co-authorship network of co-authors of Mohammed I. El–Gamal

This figure shows the co-authorship network connecting the top 25 collaborators of Mohammed I. El–Gamal. A scholar is included among the top collaborators of Mohammed I. El–Gamal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mohammed I. El–Gamal. Mohammed I. El–Gamal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Anbar, Hanan S., Abd‐Elgawad Radi, Mohammed I. El–Gamal, et al.. (2025). Protective potential of Irosustat, STX140 and the sulfonate derivative 1G in counteracting cisplatin-induced renal and hepatic toxicities: An in vivo comparative study. Life Sciences. 378. 123793–123793. 1 indexed citations

Siddiqui, Ruqaiyyah, et al.. (2023). Novel anti-Acanthamoebic properties of raloxifene sulfonate/sulfamate derivatives. Molecular and Biochemical Parasitology. 256. 111582–111582. 1 indexed citations

Abdel‐Maksoud, Mohammed S., Eslam M.H. Ali, Usama M. Ammar, et al.. (2023). Evaluation of novel pyrazol-4-yl pyridine derivatives possessing arylsulfonamide tethers as c-Jun N-terminal kinase (JNK) inhibitors in leukemia cells. European Journal of Medicinal Chemistry. 261. 115779–115779. 8 indexed citations

Siddiqui, Ruqaiyyah, Mutasem Rawas‐Qalaji, Mohammed I. El–Gamal, et al.. (2023). Novel Anti-Acanthamoebic Activities of Irosustat and STX140 and Their Nanoformulations. Antibiotics. 12(3). 561–561. 5 indexed citations

Akbar, Noor, Ruqaiyyah Siddiqui, Mohammed I. El–Gamal, et al.. (2023). Potential anti-amoebic activity of sulfonate- and sulfamate-containing carboxamide derivatives against pathogenic Acanthamoeba castellanii belonging to the genotype T4. Parasitology International. 98. 102814–102814. 3 indexed citations

Sebastian, Anusha, Vunnam Srinivasulu, Hamadeh Tarazi, et al.. (2022). Design, synthesis, and biological evaluation of a new series of pyrazole derivatives: Discovery of potent and selective JNK3 kinase inhibitors. Bioorganic & Medicinal Chemistry. 69. 116894–116894. 9 indexed citations

Zaraei, Seyed–Omar, et al.. (2022). Synthesis, biological evaluation, and molecular modeling studies of a new series of imidazothiazole or imidazooxazole derivatives as inhibitors of ectonucleoside triphosphate diphosphohydrolases (NTPDases). Medicinal Chemistry Research. 32(2). 314–325. 3 indexed citations

Akbar, Noor, Mohammed I. El–Gamal, Seyed–Omar Zaraei, et al.. (2022). Anti-amoebic activity of a series of benzofuran/benzothiophene derivatives againstAcanthamoeba castellaniibelonging to the T4 genotype. Journal of Applied Microbiology. 134(1). 2 indexed citations

Ali, Eslam M.H., Usama M. Ammar, Seyed–Omar Zaraei, et al.. (2022). Structural optimization of 4-(imidazol-5-yl)pyridine derivatives affords broad-spectrum anticancer agents with selective B-RAFV600E/p38α kinase inhibitory activity: Synthesis, in vitro assays and in silico study. European Journal of Pharmaceutical Sciences. 171. 106115–106115. 13 indexed citations

10.

El–Gamal, Mohammed I., et al.. (2021). A Review of HER4 (ErbB4) Kinase, Its Impact on Cancer, and Its Inhibitors. Molecules. 26(23). 7376–7376. 38 indexed citations

11.

Abdel‐Maksoud, Mohammed S., Mohammed I. El–Gamal, Mahmoud M. Gamal El‐Din, et al.. (2021). Discovery of New Imidazo[2,1-b]thiazole Derivatives as Potent Pan-RAF Inhibitors with Promising In Vitro and In Vivo Anti-melanoma Activity. Journal of Medicinal Chemistry. 64(10). 6877–6901. 25 indexed citations

12.

Anbar, Hanan S., et al.. (2021). Current status and future prospects of p38α/MAPK14 kinase and its inhibitors. European Journal of Medicinal Chemistry. 213. 113216–113216. 78 indexed citations

13.

Zaraei, Seyed–Omar, Hanan S. Anbar, Hamadeh Tarazi, et al.. (2021). Discovery of first-in-class imidazothiazole-based potent and selective ErbB4 (HER4) kinase inhibitors. European Journal of Medicinal Chemistry. 224. 113674–113674. 21 indexed citations

14.

Zaraei, Seyed–Omar, Mohammed I. El–Gamal, Hanan S. Anbar, et al.. (2020). Design, synthesis, biological evaluation, and modeling studies of novel conformationally-restricted analogues of sorafenib as selective kinase-inhibitory antiproliferative agents against hepatocellular carcinoma cells. European Journal of Medicinal Chemistry. 210. 113081–113081. 17 indexed citations

15.

Abduelkarem, Abduelmula R., et al.. (2019). Diarylamides in anticancer drug discovery: A review of pre-clinical and clinical investigations. European Journal of Medicinal Chemistry. 188. 112029–112029. 8 indexed citations

16.

El–Gamal, Mohammed I., Hanan S. Anbar, Hamadeh Tarazi, & Chang‐Hyun Oh. (2019). Discovery of a potent p38α/MAPK14 kinase inhibitor: Synthesis, in vitro/in vivo biological evaluation, and docking studies. European Journal of Medicinal Chemistry. 183. 111684–111684. 11 indexed citations

17.

El‐Din, Mahmoud M. Gamal, Mohammed I. El–Gamal, Mohammed S. Abdel‐Maksoud, et al.. (2019). Inhibitory effects of triarylpyrazole derivatives on LPS-induced nitric oxide and PGE2 productions in murine RAW 264.7 macrophages. Bioorganic & Medicinal Chemistry Letters. 30(4). 126884–126884. 13 indexed citations

18.

El–Gamal, Mohammed I., Saif Ullah, Seyed–Omar Zaraei, et al.. (2019). Synthesis, biological evaluation, and docking studies of new raloxifene sulfonate or sulfamate derivatives as inhibitors of nucleotide pyrophosphatase/phosphodiesterase. European Journal of Medicinal Chemistry. 181. 111560–111560. 25 indexed citations

19.

Abdel‐Maksoud, Mohammed S., Usama M. Ammar, Mohammed I. El–Gamal, et al.. (2019). Design, synthesis, and anticancer activity of imidazo[2,1-b]oxazole-based RAF kinase inhibitors. Bioorganic Chemistry. 93. 103349–103349. 25 indexed citations

20.

Abdel‐Maksoud, Mohammed S., Mohammed I. El–Gamal, Mahmoud M. Gamal El‐Din, & Chang Hyun Oh. (2018). Design, synthesis,in vitroanticancer evaluation, kinase inhibitory effects, and pharmacokinetic profile of new 1,3,4-triarylpyrazole derivatives possessing terminal sulfonamide moiety. Journal of Enzyme Inhibition and Medicinal Chemistry. 34(1). 97–109. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact